Scarica l'app Stockscreener
28.47
189.16%
19.34
Precedente Chiudi:
$9.13
Aprire:
$28
Volume 24 ore:
11.06M
Relative Volume:
47.51
Capitalizzazione di mercato:
$36.07M
Reddito:
-
Utile/perdita netta:
$-29.80M
Rapporto P/E:
-23.92
EPS:
-1.19
Flusso di cassa netto:
$-25.19M
1 W Prestazione:
+198.64%
1M Prestazione:
+152.87%
6M Prestazione:
+219.23%
1 anno Prestazione:
+180.73%
Intervallo 1D:
$22.07
$31.94
Intervallo di 1 settimana:
$8.79
$31.94
Portata 52W:
$5.00
$31.94
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Nome
Sensei Biotherapeutics Inc
Settore
Industria
Telefono
(240) 243-8000
Indirizzo
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
28.60 | 11.52M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.35 | 121.26B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.58 | 83.89B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
844.68 | 52.20B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
334.61 | 44.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
357.38 | 39.27B | 4.98B | 69.60M | 525.67M | 0.5198 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2021-07-01 | Downgrade | Berenberg | Buy → Hold |
| 2021-06-29 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-03-01 | Iniziato | Berenberg | Buy |
| 2021-03-01 | Iniziato | Citigroup | Buy |
| 2021-03-01 | Iniziato | Oppenheimer | Outperform |
| 2021-03-01 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Sensei Biotherapeutics Inc Borsa (SNSE) Ultime notizie
Sensei Biotherapeutics Acquires Faeth Therapeutics - citybiz
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition - Stocktwits
Why Is Sensei Biotherapeutics Stock Skyrocketing Wednesday?Sensei Biotherapeutics (NASDAQ:SNSE) - Benzinga
Sensei Biotherapeutics (SNSE) Shares Soar After $200M Acquisitio - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistance - HIT Consultant
Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug - Fierce Biotech
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Jumps 150% On Faeth Therapeutics Buyout And $200M Financing - Nasdaq
Sensei Biotherapeutics Closes Faeth Acquisition and Financing - TipRanks
Sensei Biotherapeutics stock soars after Faeth Therapeutics acquisition - Investing.com
SNSE: Acquisition and $200M financing position the combined entity as a leader in multi-node cancer therapies - TradingView
Sensei Biotherapeutics (SNSE) Acquires Faeth Therapeutics to Expand Pipeline - GuruFocus
SNSE: Acquisition and $200M financing advance a novel cancer therapy toward key clinical milestones - TradingView
Faeth goes public in merger with Sensei, nets $200M in stock sale - Endpoints News
What is the Moat Score of Sensei Biotherapeutics Inc.Earnings Risk Summary & Weekly High Return Stock Forecasts - mfd.ru
Sensei Biotherapeutics Expands Board, Adds Finance Expertise - TipRanks
Sensei Biotherapeutics Charts a Strategic Pivot After Halting Lead Candidate - AD HOC NEWS
Is Sensei Biotherapeutics Inc. stock a top performer YTDJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - mfd.ru
Is Sensei Biotherapeutics Inc.’s growth already priced inPortfolio Gains Report & Community Verified Swing Trade Signals - mfd.ru
Can Sensei Biotherapeutics Inc. be the next market leaderJuly 2025 Sector Moves & Weekly Setup with ROI Potential - mfd.ru
What is Sensei Biotherapeutics Incs TAM Total Addressable MarketDay Trade & Scalable Portfolio Growth Methods - baoquankhu1.vn
Market Rankings: Is Sensei Biotherapeutics Inc. a speculative investmentTrade Entry Report & Low Risk Investment Opportunities - baoquankhu1.vn
AI Stocks: What is Sensei Biotherapeutics Incs revenue forecastProfit Target & Safe Capital Allocation Plans - baoquankhu1.vn
Sensei Biotherapeutics Halts Flagship Program, Weighs Sale or Shutdown - AD HOC NEWS
Portfolio Recap: Does Sensei Biotherapeutics Inc have pricing powerDay Trade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Valuation Update: Will FG Merger II Corp Equity Right outperform its industry peersNew Guidance & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Treasury Yields: Will Sensei Biotherapeutics Inc benefit from rising consumer demandMarket Volume Summary & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Sensei Biotherapeutics Shares Experience Turbulent Week’s End - AD HOC NEWS
Can Sensei Biotherapeutics Inc. stock rebound after recent weaknessEarnings Miss & Weekly High Potential Stock Alerts - bollywoodhelpline.com
Investor Mood: Whats the MACD signal for Sensei Biotherapeutics Inc2025 Support & Resistance & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Death Cross: What is the Moat Score of Sensei Biotherapeutics IncM&A Rumor & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Retail Surge: Does EQVWS outperform in volatile markets2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Panic Selling: Is Sensei Biotherapeutics Inc in a bullish channelJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Aug Big Picture: Can Sensei Biotherapeutics Inc be the next market leaderJuly 2025 Trends & Free Community Consensus Stock Picks - baoquankhu1.vn
Published on: 2026-01-11 01:29:32 - Улправда
Earnings Update: Will Sensei Biotherapeutics Inc 4070 stock sustain dividend payouts2025 Institutional Moves & Low Risk Entry Point Tips - Bộ Nội Vụ
Why retail investors favor Sensei Biotherapeutics Inc. stockEarnings Trend Report & Accurate Technical Buy Alerts - Улправда
Sensei Biotherapeutics, Inc.Common Stock (NQ: SNSE - FinancialContent
Why Sensei Biotherapeutics Inc. stock is trending among retail tradersPortfolio Return Summary & Weekly Top Stock Performers List - Улправда
Los Angeles Daily NewsSensei Biotherapeutics, Inc.Common Stock (Nasdaq:SNSE) Stock Quote - FinancialContent
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Aug Setups: Why retail investors favor Sensei Biotherapeutics Inc stock2025 Market Outlook & Verified High Yield Trade Plans - moha.gov.vn
What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock - MSN
Will Sensei Biotherapeutics Inc. stock deliver shareholder valueChart Pattern Recognition & Grow Steadily With Our Wealth Roadmap - bollywoodhelpline.com
Sensei Biotherapeutics (NASDAQ:SNSE) Upgraded to “Hold” at Wall Street Zen - Defense World
Sensei Biotherapeutics Bolsters Leadership Amid Strategic Review - AD HOC NEWS
Sensei Biotherapeutics Updates Executive Retention and Compensation Agreements - TipRanks
Dividend Watch: Will Sensei Biotherapeutics Inc. stock deliver shareholder valueWeekly Gains Summary & Verified Momentum Watchlists - Улправда
How Sensei Biotherapeutics Inc. stock performs in rising dollar environmentEntry Point & Community Verified Swing Trade Signals - Улправда
Sensei Biotherapeutics Earnings Notes - Trefis
Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sensei Biotherapeutics Inc Azioni (SNSE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc | 10% Owner |
Dec 09 '25 |
Option Exercise |
6.40 |
395 |
2,528 |
155,983 |
| Cambrian BioPharma Inc | 10% Owner |
Dec 09 '25 |
Sale |
8.25 |
6,612 |
54,575 |
155,142 |
| Peyer James | 10% Owner |
Dec 09 '25 |
Option Exercise |
6.40 |
395 |
2,528 |
155,983 |
| Peyer James | 10% Owner |
Dec 09 '25 |
Sale |
7.96 |
3,507 |
27,903 |
155,142 |
| Peyer James | 10% Owner |
Dec 08 '25 |
Sale |
8.59 |
3,105 |
26,672 |
158,254 |
0.23%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):